# Erythropoietin (Epoetin / Darbepoetin): veterinary dose and monograph

> Erythropoietin (Epoetin / Darbepoetin) is a veterinary drug. Recombinant human erythropoietin (and the longer-acting analogue DARBEPOETIN) — an erythropoiesis-stimulating agent used to treat the non-regenerative ANAEMIA OF CHRONIC KIDNEY DISEASE (where the failing kidney no longer makes enough… Indications include non-regenerative anaemia of chronic kidney disease (the main use) — dogs and cats; other erythropoietin-deficiency / chronic-disease anaemias (selected); symptomatic anaemia where transfusion dependence is to be reduced. This monograph lists 6 reference doses for dogs, cats, rabbits and ferrets, each with route, frequency and source.

Source: https://vetmasterji.com/drugs/erythropoietin · Last reviewed: 2026-10-01

## At a glance

- **Drug class:** Veterinary drug
- **Also known as:** EPO, Epogen, Eprex, Aranesp (darbepoetin)
- **Species with doses:** Dogs, Cats, Rabbits and Ferrets
- **Routes:** SC, IM
- **Last reviewed:** 1 October 2026

## Indications

- Non-regenerative anaemia of chronic kidney disease (the main use) — dogs and cats
- Other erythropoietin-deficiency / chronic-disease anaemias (selected)
- Symptomatic anaemia where transfusion dependence is to be reduced

## Erythropoietin (Epoetin / Darbepoetin) dose by species

Doses are per administration unless stated. mg/kg doses scale with body weight; per-animal, per-quarter and infusion-rate doses are shown as the reference writes them.

### Dogs

*Erythropoietin (Epoetin / Darbepoetin) doses for dogs*

| Indication | Dose | Route | Frequency | Duration |
| --- | --- | --- | --- | --- |
| Anaemia of CKD (epoetin alfa) | 50–100 mg/kg | SC | 3× weekly, then 2× weekly, then 1–2× weekly maintenance | — |
| Anaemia of CKD (DARBEPOETIN alfa — µg/kg) | Darbepoetin 0.5–0.8 µg/kg SC once weekly; once target PCV is met, extend to every 14 or 21 days | SC | weekly, then q14–21d | — |

- Anaemia of CKD (epoetin alfa): UNITS/kg (epoetin). Plumb’s p.474: 100 U/kg SC three times weekly (50–100 U/kg if a slower response is acceptable) until the low end of the target haematocrit (37–45%), then twice weekly, then weekly; maintenance 75–100 U/kg 1–2 times weekly; adjust no more often than every 3 weeks (Cowgill); start 97 U/kg (48.4–145) three times weekly (Polzin). Supplement iron; monitor blood pressure. Up to 50% develop anti-EPO antibodies (pure red-cell aplasia) after 1–3 months. Plumb’s 10e pp.464–465 (dogs/cats, extra-label): 100 units/kg SC 3 times weekly until target PCV (usually 3–4 weeks); adjust no more often than every 3 weeks; if not controlled in 8–12 weeks add 25–50 units/kg every 3–4 weeks; maintenance 50–100 units/kg once to twice weekly; evaluate for epoetin resistance above 145 units/kg 3 times weekly. Darbepoetin: see next row.
- Anaemia of CKD (DARBEPOETIN alfa — µg/kg): Plumb’s 10e p.343 (extra-label): 0.5–0.8 µg/kg (MICROGRAMS, not units) SC weekly — the higher dose appears more effective; once target PCV is reached extend to the longest interval that holds it (e.g. every 14 or 21 days); intervals beyond 21 days are unlikely to work long-term. Supplement iron.

### Cats

*Erythropoietin (Epoetin / Darbepoetin) doses for cats*

| Indication | Dose | Route | Frequency | Duration |
| --- | --- | --- | --- | --- |
| Anaemia of CKD (epoetin alfa) | 75–100 mg/kg | SC | 3× weekly, then 50–75 U/kg 2× weekly | — |
| Anaemia of CKD (DARBEPOETIN alfa — µg/kg) | Darbepoetin 1 µg/kg SC once weekly (reported range 0.25–1.5 µg/kg/week); once target PCV is met, extend to every 14 or 21 days | SC | weekly, then q14–21d | — |

- Anaemia of CKD (epoetin alfa): UNITS/kg (epoetin). Plumb’s p.474: consider when PCV <20%; 75–100 U/kg SC three times weekly until PCV reaches the low target range (30–40%), then 50–75 U/kg twice weekly (Scherk; Chew). Give iron from the start (ferrous sulfate 5–50 mg per cat per day). Monitor PCV and blood pressure; antibody-mediated red-cell aplasia possible.
- Anaemia of CKD (DARBEPOETIN alfa — µg/kg): Plumb’s 10e p.343 (extra-label): 1 µg/kg (MICROGRAMS, not units) SC once weekly; other recommendations range 0.25–1.5 µg/kg per week. Once target PCV is met extend the interval (e.g. every 14 or 21 days). Supplement iron.

### Rabbits

*Erythropoietin (Epoetin / Darbepoetin) doses for rabbits*

| Indication | Dose | Route | Frequency | Duration |
| --- | --- | --- | --- | --- |
| Anaemia | 50–150 mg/kg | SC | every 2–3 days, then weekly for ≥4 weeks | — |

- Anaemia: UNITS/kg. Plumb’s p.474 (Ivey & Morrisey 2000): 50–150 U/kg SC every 2–3 days until PCV is normal, then weekly for at least 4 weeks.

### Ferrets

*Erythropoietin (Epoetin / Darbepoetin) doses for ferrets*

| Indication | Dose | Route | Frequency | Duration |
| --- | --- | --- | --- | --- |
| Anaemia | 50–150 mg/kg | IM | 3× weekly, then weekly | — |

- Anaemia: UNITS/kg. Plumb’s p.474 (Williams 2000): 50–150 U/kg IM three times weekly, reducing to weekly once RBC indices improve.

## Contraindications

Uncontrolled hypertension (EPO raises blood pressure). Iron deficiency without supplementation (EPO won't work). Known hypersensitivity. Over-rapid correction / targeting a normal-high haematocrit (thrombosis/hypertension risk). Prior anti-EPO antibody reaction. Pregnancy (caution).

## Species-specific warnings

> **Caution:** Cats: CKD cats are the classic patients — use darbepoetin (less PRCA risk), supplement iron, monitor blood pressure and haematocrit, and target a modest HCT.

## Adverse effects

- ANTI-EPO ANTIBODY formation → refractory pure red cell aplasia (worse with epoetin than darbepoetin)
- Systemic HYPERTENSION (monitor/treat)
- Iron depletion (functional) — needs iron supplementation
- Injection-site reaction; polycythaemia/thrombosis if over-corrected; seizures (rare, rapid rise)

## Drug interactions

- Iron status: adequate iron is REQUIRED for a response (functional iron deficiency develops) — co-supplement iron
- Antihypertensives: may be needed to control EPO-induced hypertension
- No major small-molecule pharmacokinetic interactions

## Pregnancy and lactation

Limited data; use only if clearly needed.

## Monitoring

- Haematocrit/PCV (titrate to a TARGET ~30–35 %, not normal-high) and reticulocytes
- Iron status (supplement iron) — required for response
- Blood pressure (EPO-induced hypertension)
- Watch for a plateau/decline in HCT despite therapy = possible anti-EPO antibody PRCA (stop the drug)

## Toxicity and overdose

The defining veterinary hazard is immune-mediated: anti-EPO antibodies can neutralise the drug and cross-react with endogenous EPO, causing a worsening, transfusion-dependent PURE RED CELL APLASIA (more common with epoetin; darbepoetin is less immunogenic). Other effects: hypertension, polycythaemia/thrombosis and seizures if the haematocrit is raised too high/too fast, and functional iron deficiency. Hence targeting a modest (not normal) haematocrit and monitoring.

Management: No specific antidote. For over-correction (polycythaemia/hypertension), withhold the drug and manage blood pressure; phlebotomy if severe polycythaemia. If PRCA develops, STOP the drug (it perpetuates the problem) and support with transfusions ± immunosuppression; recovery of endogenous EPO may occur over time. Monitor HCT/blood pressure.

## Clinical pearls

- The treatment for the anaemia of chronic kidney disease — it does what the failing kidney can't (make EPO); prefer DARBEPOETIN (less immunogenic, weekly dosing) over epoetin
- ALWAYS co-supplement IRON (EPO fails without it) and monitor BLOOD PRESSURE (it causes hypertension)
- Target a MODEST haematocrit (~30–35 %), not a normal one — over-correction risks hypertension, thrombosis and seizures
- The dreaded complication is antibody-mediated pure red cell aplasia (HCT falls despite treatment, transfusion-dependent) — recognise it and STOP the drug; darbepoetin lowers this risk

## Mechanism of action

Recombinant erythropoietin (and the hyperglycosylated, longer-acting darbepoetin) binds erythropoietin receptors on erythroid progenitor cells in the bone marrow, stimulating their proliferation, differentiation and survival into mature red blood cells — replacing the erythropoietin that a diseased kidney fails to produce and thereby correcting the anaemia. Because they are human/engineered proteins, they can provoke neutralising antibodies in animals; darbepoetin's modified structure is less immunogenic and longer-acting (less frequent dosing).

## Formulations and products

- Epoetin alfa 2000 / 4000 / 10000 IU vial/syringe
- Darbepoetin alfa 25 / 40 / 60 mcg syringe (long-acting)
- Eprex / Epogen (epoetin) — 2000 / 4000 / 10000 IU, SC/IV injection (human-label)
- Aranesp (darbepoetin) — 25 / 40 / 60 mcg syringe, SC injection (long-acting) (human-label)

## Storage

Refrigerate (2–8 °C), do NOT freeze; protect from light. Do not shake (protein). Discard if frozen/discoloured.

## Before you use this dose

> **Caution:** Reference doses for veterinary professionals. Confirm the dose against the product label, the patient’s condition, current guidance and local regulations before use; the attending veterinarian remains responsible for every clinical decision.

## Other hormones, emergency drugs, supplements and other drugs

- [Doxapram](https://vetmasterji.com/drugs/doxapram)
- [Doxorubicin](https://vetmasterji.com/drugs/doxorubicin)
- [Enoxaparin](https://vetmasterji.com/drugs/enoxaparin)
- [Epinephrine](https://vetmasterji.com/drugs/epinephrine)
- [Estriol](https://vetmasterji.com/drugs/estriol)
- [Ferrous Sulfate](https://vetmasterji.com/drugs/ferrous-sulfate)
- [Finasteride](https://vetmasterji.com/drugs/finasteride)
- [Fludrocortisone](https://vetmasterji.com/drugs/fludrocortisone)

## Frequently asked questions

### What is the dose of Erythropoietin (Epoetin / Darbepoetin) for dogs?

Reference doses for Erythropoietin (Epoetin / Darbepoetin) in dogs: 50–100 mg/kg SC 3× weekly, then 2× weekly, then 1–2× weekly maintenance (Anaemia of CKD (epoetin alfa)); Darbepoetin 0.5–0.8 µg/kg SC once weekly; once target PCV is met, extend to every 14 or 21 days SC weekly, then q14–21d (Anaemia of CKD (DARBEPOETIN alfa — µg/kg)). Confirm against the label and the patient before use.

### What is the dose of Erythropoietin (Epoetin / Darbepoetin) for cats?

Reference doses for Erythropoietin (Epoetin / Darbepoetin) in cats: 75–100 mg/kg SC 3× weekly, then 50–75 U/kg 2× weekly (Anaemia of CKD (epoetin alfa)); Darbepoetin 1 µg/kg SC once weekly (reported range 0.25–1.5 µg/kg/week); once target PCV is met, extend to every 14 or 21 days SC weekly, then q14–21d (Anaemia of CKD (DARBEPOETIN alfa — µg/kg)). Confirm against the label and the patient before use.

### What is the dose of Erythropoietin (Epoetin / Darbepoetin) for rabbits?

Reference doses for Erythropoietin (Epoetin / Darbepoetin) in rabbits: 50–150 mg/kg SC every 2–3 days, then weekly for ≥4 weeks (Anaemia). Confirm against the label and the patient before use.

### When should Erythropoietin (Epoetin / Darbepoetin) not be used?

Uncontrolled hypertension (EPO raises blood pressure). Iron deficiency without supplementation (EPO won't work). Known hypersensitivity. Over-rapid correction / targeting a normal-high haematocrit (thrombosis/hypertension risk). Prior anti-EPO antibody reaction. Pregnancy (caution).

### What are the side effects of Erythropoietin (Epoetin / Darbepoetin) in animals?

ANTI-EPO ANTIBODY formation → refractory pure red cell aplasia (worse with epoetin than darbepoetin); Systemic HYPERTENSION (monitor/treat); Iron depletion (functional) — needs iron supplementation; Injection-site reaction; polycythaemia/thrombosis if over-corrected; seizures (rare, rapid rise).

## Sources

- Plumb's Veterinary Drug Handbook
- Merck Veterinary Manual, 11th edition

---

VetMasterJi is a clinical decision-support and education platform for veterinary professionals and students. It does not provide veterinary advice, diagnosis or treatment for specific animals. All drug doses, calculators and differentials are references that must be independently verified before clinical use; the attending registered veterinarian remains solely responsible for every clinical decision.